Skip to main content
Caplight Logo









Phenotypeca

Phenotypeca

Private
NottinghamHealthcare & Life Scienceshttps://phenotypeca.com

Last Round

Grant

Feb 17, 2022

Total Funding Raised

$2.39M

Company Overview

Phenotypeca operates in Healthcare & Life Sciences and is based in Nottingham. Its latest recorded funding round was a Grant round in February 2022.

Phenotypeca is a biotechnology company that uses yeast breeding technologies and synthetic biology to produce proteins and peptides for the biopharmaceutical, consumer health, and other industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Phenotypeca Comparables

Compare Phenotypeca with similar companies based on industry and business-model similarity.

Phenotypeca comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vectron Biosolutions
74%
Premas Biotech
73%
Sartorius Aktiengesellschaft
72%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Phenotypeca Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2022
GrantOct 5, 2021
SeedMar 1, 2021
GrantMay 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Phenotypeca Investors

Notable investors and investment history

Phenotypeca investors
InvestorRounds
Innovate UKGrant
Bill & Melinda Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 83% MoM.

  • Oct 30, 2024

    Monthly visitors grew 233% MoM, reaching 1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Phenotypeca Filings

Explore SEC and related filing metadata, where available.

Phenotypeca filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Phenotypeca's valuation, stock price, and market status.

Is Phenotypeca a public or private company?

Phenotypeca is a private company.

What is the current stock price of Phenotypeca?

Phenotypeca is a private company, so its shares have no public market price. Caplight tracks Phenotypeca's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Phenotypeca worth (valuation)?

Valuation information for Phenotypeca is not publicly available.

Can I buy Phenotypeca stock?

Phenotypeca shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Phenotypeca's last funding round?

Phenotypeca's most recent funding round was Grant on February 17, 2022.

Who are the main investors in Phenotypeca?

Key investors in Phenotypeca include Innovate UK, Bill & Melinda Gates Foundation.

Will Phenotypeca IPO soon?

No public IPO plans have been announced for Phenotypeca.

How can I track Phenotypeca secondary market activity?

Caplight tracks bids, offers, and trades in Phenotypeca's shares on secondary markets.

Firmographic Details

HeadquartersNottingham
Employee Range14
Year Founded2018
Last FundingFeb 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?